KDR and hepatocellular carcinoma: Some previous studies have reported that high expression of the angiogenic factors VEGF, basic FGF, and platelet-derived growth factor receptor are detected in patients with HCC, suggesting that VEGFR, FGFR, and PDGFR are likely targets of dovitinib.